JP2014530631A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530631A5 JP2014530631A5 JP2014537601A JP2014537601A JP2014530631A5 JP 2014530631 A5 JP2014530631 A5 JP 2014530631A5 JP 2014537601 A JP2014537601 A JP 2014537601A JP 2014537601 A JP2014537601 A JP 2014537601A JP 2014530631 A5 JP2014530631 A5 JP 2014530631A5
- Authority
- JP
- Japan
- Prior art keywords
- sucrose solution
- arsine
- dihydroquercetin
- glycyrrhizin
- sid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RBFQJDQYXXHULB-UHFFFAOYSA-N Arsine Chemical compound [AsH3] RBFQJDQYXXHULB-UHFFFAOYSA-N 0.000 claims description 6
- CXQWRCVTCMQVQX-LSDHHAIUSA-N Taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 claims description 6
- LPLVUJXQOOQHMX-MYOOOWEVSA-N Glycyrrhizic acid Natural products O=C(O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](C(=O)O)O2)[C@@H](O[C@@H]2C(C)(C)[C@H]3[C@@](C)([C@H]4C(=O)C=C5[C@](C)([C@]4(C)CC3)CC[C@]3(C)[C@H]5C[C@](C(=O)O)(C)CC3)CC2)O1 LPLVUJXQOOQHMX-MYOOOWEVSA-N 0.000 claims description 4
- 239000004378 Glycyrrhizin Substances 0.000 claims description 4
- OHLBTNZSOHMDGY-JNMXELLOSA-N Mukurozioside IIb Natural products O(C/C(=C\CC/C(=C\CC/C(=C\CO[C@H]1[C@H](O[C@@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](O)[C@@H](CO)O1)/C)/C)/C)[C@H]1[C@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@@H](O[C@H]2[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O2)[C@H](O)[C@@H](CO)O1 OHLBTNZSOHMDGY-JNMXELLOSA-N 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- -1 dihydrochalcone glucoside Chemical class 0.000 claims description 3
- WRPAFPPCKSYACJ-ZBYJYCAASA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[[(3S,8R,9R,10S,11R,13R,14S,17R)-17-[(5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-hydroxy-6-methylheptan-2-yl]-11-hydrox Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H](CCC(C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@@H]3[C@]2(C)CC1)C)C(C)(C)O)[C@H]1O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]1O WRPAFPPCKSYACJ-ZBYJYCAASA-N 0.000 claims description 2
- XJIPREFALCDWRQ-UYQGGQRHSA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6S)-3,4-dihydroxy-6-[(3R,6R)-2-hydroxy-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-11-hydroxy-4,4,9,13,14-pentamethyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclop Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJIPREFALCDWRQ-UYQGGQRHSA-N 0.000 claims description 2
- RMLYXMMBIZLGAQ-HZMBPMFUSA-N (2S,4S)-4-amino-2-hydroxy-2-(1H-indol-3-ylmethyl)pentanedioic acid Chemical compound C1=CC=C2C(C[C@](O)(C[C@H](N)C(O)=O)C(O)=O)=CNC2=C1 RMLYXMMBIZLGAQ-HZMBPMFUSA-N 0.000 claims description 2
- QZOALWMSYRBZSA-XSAMIUIESA-N Osladin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1C[C@@H]2C(=O)C[C@H]3[C@@H]4CCC([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)C1O[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@H](C)CC1)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O QZOALWMSYRBZSA-XSAMIUIESA-N 0.000 claims description 2
- 108010010165 curculin Proteins 0.000 claims description 2
- GLLUYNRFPAMGQR-PPNXFBDMSA-N glycyphyllin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GLLUYNRFPAMGQR-PPNXFBDMSA-N 0.000 claims description 2
- ALAGDBVXZZADSN-UHFFFAOYSA-N pentazine Chemical compound C1=NN=NN=N1 ALAGDBVXZZADSN-UHFFFAOYSA-N 0.000 claims description 2
- 150000003085 polypodoside A derivatives Polymers 0.000 claims description 2
- DMRIOWKDQLGGAP-FPYDNAILSA-N polypodoside B group Chemical group [C@@H]12CC[C@H]([C@H](C)[C@H]3CC[C@H](C)[C@@H](OC4OC(C)C(O)C(O)C4O)O3)[C@@]1(C)CC[C@H]1C2=CC(=O)[C@H]2C[C@H](CC[C@]12C)OC1OC(CO)C(O)C(O)C1O DMRIOWKDQLGGAP-FPYDNAILSA-N 0.000 claims description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 2
- 150000007949 saponins Chemical class 0.000 claims description 2
- 239000000892 thaumatin Substances 0.000 claims description 2
- 235000010436 thaumatin Nutrition 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 4
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 claims 4
- 239000005720 sucrose Substances 0.000 claims 4
- GHBNZZJYBXQAHG-KUVSNLSMSA-N (2R,3R,4S,5S,6R)-2-[[(2R,3S,4S,5R,6R)-6-[[(3S,8S,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H](CC[C@@H](C)[C@@H]1[C@]2(C[C@@H](O)[C@@]3(C)[C@H]4C(C([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]6[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O6)O)O5)O)CC4)(C)C)=CC[C@H]3[C@]2(C)CC1)C)C(C)(C)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GHBNZZJYBXQAHG-KUVSNLSMSA-N 0.000 claims 1
- GSTCPEBQYSOEHV-QNDFHXLGSA-N 1-[2,6-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 GSTCPEBQYSOEHV-QNDFHXLGSA-N 0.000 claims 1
- 239000001183 FEMA 4495 Substances 0.000 claims 1
- 239000001689 FEMA 4674 Substances 0.000 claims 1
- CWBZAESOUBENAP-IKACCGSXSA-N Naringin dihydrochalcone Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](OC=2C=C(O)C(C(=O)CCC=3C=CC(O)=CC=3)=C(O)C=2)O[C@@H](CO)[C@H](O)[C@H]1O CWBZAESOUBENAP-IKACCGSXSA-N 0.000 claims 1
- 241001092459 Rubus Species 0.000 claims 1
- YWPVROCHNBYFTP-OSHKXICASA-N Rubusoside Chemical compound O([C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YWPVROCHNBYFTP-OSHKXICASA-N 0.000 claims 1
- XSDXQNVJNSCZNC-UHFFFAOYSA-N [5,7-dihydroxy-2-(4-methoxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl] acetate Chemical compound C1=CC(OC)=CC=C1C1C(OC(C)=O)C(=O)C2=C(O)C=C(O)C=C2O1 XSDXQNVJNSCZNC-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
Description
他の追加の甘味増強剤は、グリシフィリン、イソモグロシドＶ、モグロシドＩＶ、シアメノシドＩ、ネオモグロシド、ムクロジオシドＩＩｂ、（＋）−ヘルナンズルシン、４β−ヒドロキシヘルナンズルシン、バイユノシド、フロミソシドＩ、ブリオズルコシド、ブリオシド、ブリオノシド、アブルソシドＡ〜Ｅ、シクロカリオシドＡ、シクロカリオシドＩ、アルビジアサポニンＡ〜Ｅ、グリチルリチン、アラボグリチルリチン、ペリアンドリンＩ〜Ｖ、プテロカリオシドＡおよびＢ、オスラジン、ポリポドシドＡおよびＢ、テロスモシドＡ８〜１８、フィロズルシン、フアングキオシドＥ、ネオアスチルビン、モナチン、３−アセトキシ−５，７−ジヒドロキシ−４’−メトキシフラバノン、２Ｒ，３Ｒ−（＋）−３−アセトキシ−５，７，４’ −トリヒドロキシフラバノン、（２Ｒ，３Ｒ）−ジヒドロケルセチン３−Ｏ−アセテート、ジヒドロケルセチン３−Ｏ−アセテート４’−メチルエーテル、ブラゼイン、クルクリン、マビンリン、モネリン、ネオクリン、ペンタジン、タウマチン、またはそれらの組み合わせを含んでもよい。
Claims (3)
- 混合物が１．２５％以下のスクロース溶液に等甘味度な、より特に１％のスクロース溶液に等甘味度な濃度で添加された、請求項７に記載の消費可能な組成物。
- トリロバチン、ヘスペレチンジヒドロカルコングルコシド、ナリンギンジヒドロカルコン、モグロシドＶ、ルオハングオ抽出物、ルブソシド、ルブス抽出物、グリシフィリン、イソモグロシドＶ、モグロシドＩＶ、シアメノシドＩ、ネオモグロシド、ムクロジオシドＩＩｂ、（＋）−ヘルナンズルシン、４β-ヒドロキシヘルナンズルシン、バイユノシド、フロミソシドＩ、ブリオズルコシド、ブリオシド、ブリオノシド、アブルソシドＡ〜Ｅ、シクロカリオシドＡ、シクロカリオシドＩ、アルビジアサポニンＡ〜Ｅ、グリチルリチン、アラボグリチルリチン、ペリアンドリンＩ〜Ｖ、プテロカリオシドＡおよびＢ、オスラジン、ポリポドシドＡおよびＢ、テロスモシドＡ８〜１８、フィロズルシン、フアングキオシドＥ、ネオアスチルビン、モナチン、３−アセトキシ−５，７−ジヒドロキシ−４’−メトキシフラバノン、２Ｒ，３Ｒ−（＋）−３−アセトキシ−５，７，４’−トリヒドロキシフラバノン、（２Ｒ，３Ｒ）−ジヒドロケルセチン３−Ｏ−アセテート、ジヒドロケルセチン３−Ｏ−アセテート４’−メチルエーテル、ブラゼイン、クルクリン、マビンリン、モネリン、ネオクリン、ペンタジン、タウマチン、またはそれらの組み合わせからなる群から選択される１または２以上の化合物を含む、請求項５〜１１のいずれか一項に記載の消費可能な組成物。
- 混合物を、１．２５％以下のスクロース溶液に等甘味度であり、より特に１％スクロース溶液に等甘味度である濃度で添加する、請求項１４〜１６のいずれか一項に記載の方法。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161550495P | 2011-10-24 | 2011-10-24 | |
| US61/550,495 | 2011-10-24 | ||
| PCT/EP2012/071088 WO2013060746A1 (en) | 2011-10-24 | 2012-10-24 | Compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014530631A JP2014530631A (ja) | 2014-11-20 |
| JP2014530631A5 true JP2014530631A5 (ja) | 2015-12-17 |
| JP6353364B2 JP6353364B2 (ja) | 2018-07-04 |
Family
ID=47115891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537601A Active JP6353364B2 (ja) | 2011-10-24 | 2012-10-24 | 組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140370177A1 (ja) |
| EP (1) | EP2770843B1 (ja) |
| JP (1) | JP6353364B2 (ja) |
| CN (1) | CN104039166B (ja) |
| BR (1) | BR112014009376B1 (ja) |
| IN (1) | IN2014CN02970A (ja) |
| MX (1) | MX354411B (ja) |
| SG (1) | SG11201401335QA (ja) |
| WO (1) | WO2013060746A1 (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201418899D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | System for radiopharmaceutical production |
| GB201418897D0 (en) | 2014-10-23 | 2014-12-10 | Univ Hull | Methods and apparatus for the analysis of compounds |
| GB201418893D0 (en) * | 2014-10-23 | 2014-12-10 | Univ Hull | Monolithic body |
| JP6976173B2 (ja) * | 2015-03-10 | 2021-12-08 | レイクスユニフェルシテイト フローニンゲン | ステビオールグリコシドの酵素的修飾方法、それによって得られる修飾ステビオールグリコシド、およびそれらの甘味料としての使用 |
| WO2018122383A1 (en) * | 2016-12-30 | 2018-07-05 | Red Bull Gmbh | Sweetening compositions |
| PL3504983T3 (pl) * | 2016-12-30 | 2024-02-05 | Red Bull Gmbh | Kompozycje słodzące |
| WO2021214008A1 (en) | 2020-04-20 | 2021-10-28 | Givaudan Sa | Compositions |
| CN111132558A (zh) | 2017-10-23 | 2020-05-08 | 西姆莱斯有限公司 | 芳香组合物 |
| US20200221722A1 (en) * | 2019-01-15 | 2020-07-16 | Kween Foods LLC | Granola butter product and process of making a granola butter product |
| WO2021043842A1 (en) * | 2019-09-05 | 2021-03-11 | Firmenich Sa | Flavanone derivatives and their use as sweetness enhancers |
| WO2021130046A1 (en) * | 2019-12-23 | 2021-07-01 | Firmenich Sa | Triterpene glucuronides and their use as flavor modifiers |
| GB202007984D0 (en) | 2020-05-28 | 2020-07-15 | Givaudan Sa | Compositions |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8293305B2 (en) * | 2005-10-11 | 2012-10-23 | Purecircle Sdn Bhd | Process for manufacturing a sweetener and use thereof |
| WO2007121604A2 (en) * | 2006-04-20 | 2007-11-01 | Givaudan Sa | Method relating to sweetness enhancement |
| US20100092638A1 (en) | 2006-10-24 | 2010-04-15 | Chad Allen Hansen | Consumables |
| US9101161B2 (en) * | 2006-11-02 | 2015-08-11 | The Coca-Cola Company | High-potency sweetener composition with phytoestrogen and compositions sweetened therewith |
| BRPI0820009A2 (pt) * | 2007-12-03 | 2015-05-19 | Dsm Ip Assets Bv | Composições nutracêuticas contendo extrato de estévia ou constituintes do extrato de estévia e uso das mesmas |
| CN101220062A (zh) * | 2008-01-23 | 2008-07-16 | 石任兵 | 一种同时制备甜菊苷和莱鲍迪苷a的方法 |
| US20120164083A1 (en) * | 2009-09-04 | 2012-06-28 | Redpoint Bio Corporation | Sweetness Enhancers Including Rebaudioside A or D |
-
2012
- 2012-10-24 JP JP2014537601A patent/JP6353364B2/ja active Active
- 2012-10-24 BR BR112014009376-8A patent/BR112014009376B1/pt active IP Right Grant
- 2012-10-24 SG SG11201401335QA patent/SG11201401335QA/en unknown
- 2012-10-24 US US14/352,223 patent/US20140370177A1/en active Pending
- 2012-10-24 MX MX2014004694A patent/MX354411B/es active IP Right Grant
- 2012-10-24 WO PCT/EP2012/071088 patent/WO2013060746A1/en active Application Filing
- 2012-10-24 EP EP12780165.2A patent/EP2770843B1/en active Active
- 2012-10-24 IN IN2970CHN2014 patent/IN2014CN02970A/en unknown
- 2012-10-24 CN CN201280052169.0A patent/CN104039166B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530631A5 (ja) | ||
| BRPI0715563B8 (pt) | ventilador mecânico controlável | |
| JP2009531457A5 (ja) | ||
| BR112014031068A2 (pt) | derivados piridinona e piridazinona | |
| EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
| JP2013523191A5 (ja) | ||
| CL2013001386A1 (es) | Conjunto de composiciones nutricionales para lactantes que comprende una primera composicion para lactantes de 0 a 4 semanas, una segunda composicion para lactantes de 4 a 8 semanas, y una tercera composicion para lactantes de 3 a 6 meses, cada una con distintas densidades caloricas; y su uso para reducir la obesidad, diabetes y enfermedades cardiovasculares posteriormente en la vida. | |
| BR112014005134A2 (pt) | composição farmacêutica de dissolução rápida | |
| UY30762A1 (es) | Sal fumarato de (alfa s, beta r)-6-bromo-alfa-[2(dimetilamino) etil]-2-metoxi-alfa-1-naftalenil-beta-fenil-3-quinolinaetanol | |
| ATE491446T1 (de) | Ligustilid zur behandlung von erkrankungen des zentralen nervensystems | |
| NO20074559L (no) | O-Desmetylvenlafaxin og bazedoxifen kombinasjonsprodukt og anvendelser derav | |
| BR112014009376A2 (pt) | composições | |
| BR112013011882A2 (pt) | fórmula nutricional adaptada à idade com densidade calórica particularmente adaptada para bebês e crianças | |
| FR2925326B1 (fr) | Utilisation d'un hydrolysat de mais en tant que principe actif activateur de la synthese des aquaporines | |
| BR112013003216A2 (pt) | composições sintéticas de ácido biliar e métodos | |
| NO20075758L (no) | Polymorfer av 3-0-(3',3'-dimetylsuccinyl) betulin syre di-N-metyl-D-glukamin | |
| JP2015535241A5 (ja) | ||
| BR112014000917A2 (pt) | composições | |
| MacKenzie | Sitting ducks for bird flu | |
| Chan | Juniors needed support over MMC/MTAS | |
| Maraka et al. | Cost-effectiveness of dental surgery procedures: a call for strengthening the evidence: reply | |
| Rød et al. | Effects of social defeat on sleep and behavior: Importance of the confrontational behavior | |
| Phelps et al. | Sex Differences In The Alveolar Macrophage Proteome In Response To Treatment With Exogenous Surfactant Protein-A | |
| Smith et al. | A95 INDOOR AND OUTDOOR POLLUTANTS AND RESPIRATORY HEALTH: Acetaminophen Potentiates Respiratory Responses To Environmental Tobacco Smoke | |
| Nuwer | An unhealthy favouritism |